IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification

10.3324/haematol.2019.221176

Saved in:

Bibliographic Details
Main Authors:	Teoh, Phaik Ju, Chung, Tae-Hoon, Chng, Pamela YZ, Toh, Sabrina HM, Chng, Wee Joo
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Language:	English
Published:	FERRATA STORTI FOUNDATION 2021
Subjects:	Science & Technology Life Sciences & Biomedicine Hematology SOLUBLE INTERLEUKIN-6 RECEPTOR ADVERSE PROGNOSTIC-FACTOR MONOCLONAL-ANTIBODY RNA BORTEZOMIB STAT3 CANCER PATHOGENESIS EXPRESSION SILTUXIMAB
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/206181
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-206181
record_format	dspace
spelling	sg-nus-scholar.10635-2061812023-09-20T21:56:33Z IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification Teoh, Phaik Ju Chung, Tae-Hoon Chng, Pamela YZ Toh, Sabrina HM Chng, Wee Joo CANCER SCIENCE INSTITUTE OF SINGAPORE DEAN'S OFFICE (MEDICINE) Science & Technology Life Sciences & Biomedicine Hematology SOLUBLE INTERLEUKIN-6 RECEPTOR ADVERSE PROGNOSTIC-FACTOR MONOCLONAL-ANTIBODY RNA BORTEZOMIB STAT3 CANCER PATHOGENESIS EXPRESSION SILTUXIMAB 10.3324/haematol.2019.221176 HAEMATOLOGICA 105 5 1391-1404 2021-11-15T08:02:51Z 2021-11-15T08:02:51Z 2020-05-01 2021-11-10T03:04:21Z Article Teoh, Phaik Ju, Chung, Tae-Hoon, Chng, Pamela YZ, Toh, Sabrina HM, Chng, Wee Joo (2020-05-01). IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification. HAEMATOLOGICA 105 (5) : 1391-1404. ScholarBank@NUS Repository. https://doi.org/10.3324/haematol.2019.221176 03906078 15928721 https://scholarbank.nus.edu.sg/handle/10635/206181 en FERRATA STORTI FOUNDATION Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	Science & Technology Life Sciences & Biomedicine Hematology SOLUBLE INTERLEUKIN-6 RECEPTOR ADVERSE PROGNOSTIC-FACTOR MONOCLONAL-ANTIBODY RNA BORTEZOMIB STAT3 CANCER PATHOGENESIS EXPRESSION SILTUXIMAB
spellingShingle	Science & Technology Life Sciences & Biomedicine Hematology SOLUBLE INTERLEUKIN-6 RECEPTOR ADVERSE PROGNOSTIC-FACTOR MONOCLONAL-ANTIBODY RNA BORTEZOMIB STAT3 CANCER PATHOGENESIS EXPRESSION SILTUXIMAB Teoh, Phaik Ju Chung, Tae-Hoon Chng, Pamela YZ Toh, Sabrina HM Chng, Wee Joo IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification
description	10.3324/haematol.2019.221176
author2	CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet	CANCER SCIENCE INSTITUTE OF SINGAPORE Teoh, Phaik Ju Chung, Tae-Hoon Chng, Pamela YZ Toh, Sabrina HM Chng, Wee Joo
format	Article
author	Teoh, Phaik Ju Chung, Tae-Hoon Chng, Pamela YZ Toh, Sabrina HM Chng, Wee Joo
author_sort	Teoh, Phaik Ju
title	IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification
title_short	IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification
title_full	IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification
title_fullStr	IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification
title_full_unstemmed	IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification
title_sort	il6r-stat3-adar1 (p150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification
publisher	FERRATA STORTI FOUNDATION
publishDate	2021
url	https://scholarbank.nus.edu.sg/handle/10635/206181
_version_	1779154225323835392

IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification

Similar Items